Find clinical trials for Non-Small-Cell Lung Cancer in Houston, TX
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near Houston, TX, USA:
3-DXd will be evaluated in participants with metastatic or unresectable NSCLC with EGFR activating mutation or squamous or non-squamous NSCL...
Phase 1
Houston, Texas, United States and 36 other locations
is a multi-center, open label, Phase 1b study of NXP900 in combination with osimertinib in subjects with advanced, progressing, EGFR-mutated non...
Phase 1
Houston, Texas, United States and 5 other locations
N2) NSCLC (per the 8th International Association for the Study of Lung Cancer classification). The primary objective of this study ...
Phase 2
Houston, Texas, United States and 8 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Houston, Texas, United States and 230 other locations
in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung cancer...
Phase 3
Sugar Land, Texas, United States and 263 other locations
Non-Squamous Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer mort...
Phase 2, Phase 3
Houston, Texas, United States and 61 other locations
This is a Phase II, multi-center, open-label platform study evaluating novel combination treatment options in participants with locally advanced or m...
Phase 2
Houston, Texas, United States and 82 other locations
"study drugs". The study is focused on patients who have advanced non-small cell lung cancer (NSCLC).The...
Phase 2
Houston, Texas, United States and 52 other locations
growth factor A (VEGF-A) in participants with non-small cell lung cancer (NSCLC).The study will compris...
Phase 1
Houston, Texas, United States and 46 other locations
to to explore the reasonable dosage and evaluate the efficacy, safety and tolerability of HLX43 (Anti-PD-L1 ADC) in Patients with Advanced Non...
Phase 2
Houston, Texas, United States and 1 other location
Clinical trials
Research sites
Resources
Legal